Some patients may lose more weight, while others may lose less
In a meta-analysis of nine studies, oral ALA treatment, compared to placebo, revealed a reduction in the NIS (muscle weakness, reflex loss, sensation loss), the NIS-LL (motor nerve function and reflexes in the lower limbs), and the TSS [58]
Clinical studies consistently show that formulations containing luteolin can suppress key inflammatory mediators, such as IL-6, IL-1, TNF- in humans
The result is a deeper, more even tan that builds over days and lasts well beyond the dosing period
Muscle Building & Performance Increases lean mass and strength in resistance-trained adults Enhances muscle protein synthesis rates Improves exercise recovery and adaptation Reduces muscle damage markers post-exercise Tissue Repair & Recovery Accelerates healing of tendons and ligaments Enhances collagen synthesis and deposition Reduces recovery time from musculoskeletal injuries Supports surgical wound healing Metabolic Health Improves glucose disposal in insulin resistance Enhances insulin sensitivity by 34% in prediabetes Supports nutrient partitioning and utilization May reduce cardiovascular risk factors Additional Clinical Applications Important Consideration: All applications of IGF-1 LR3 are considered off-label use
Pharmacy Compounding Advisory Committee meeting, July 2026
